Screening of enzymatic synthesis and expression of Lewis determinants in human colorectal carcinoma

Fernández-Briera, Almudena; Cuevas, Elisa; Gil‐Martín, Emilio

doi:10.17235/reed.2015.3789/2015

Cited by 1 publication

(1 citation statement)

References 38 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…SialylLewisX, with high expression in breast cancer, ovarian cancer, liver cancer, and colorectal cancer, has been proved to be a tumor-associated antigen. 32 – 35 Engineering anti-Lewis-Y hu3S193 and IGN311 antibodies have been tested as passive immunotherapy approaches of epithelial cancers and may be applied clinically. 36 , 37 Core-fucosylated AFP (AFP - L3) compared to AFP has a more specific value of the diagnosis of liver cancer.…”

Section: Discussionmentioning

confidence: 99%

High TSTA3 Expression as a Candidate Biomarker for Poor Prognosis of Patients With ESCC

Yang

Kong

Yang

et al. 2018

Technol Cancer Res Treat

View full text Add to dashboard Cite

Esophageal squamous cell carcinoma is the sixth most lethal cancer worldwide and the fourth most lethal cancer in China. Tissue-specific transplantation antigen P35B codifies the enzyme GDP-d-mannose-4,6-dehydratase, which participates in the biosynthesis of GDP-l-fucose. GDP-l-fucose is an important substrate involved in the biosynthesis of many glycoproteins. Cancer cells are often accompanied by the changes in glycoprotein structure, which affects the adhesion, invasion, and metastasis of cells. It is not clear whether tissue-specific transplantation antigen P35B has any effect on the development of esophageal squamous cell carcinoma. We used an immunohistochemical method to assess the expression of tissue-specific transplantation antigen P35B in 104 esophageal squamous cell carcinoma samples. The results showed tissue-specific transplantation antigen P35B expression was associated with some clinical features in patients, such as age (P = .017), clinical stage (P = .010), and lymph node metastasis (P = .043). Kaplan-Meier analysis and log-rank test showed that patients with esophageal squamous cell carcinoma having high tissue-specific transplantation antigen P35B expression had a worse prognosis compared to the patients with low expression (P = .048). Multivariate Cox proportional hazards regression model showed that high expression of tissue-specific transplantation antigen P35B could predict poor prognosis for patients with esophageal squamous cell carcinoma independently. In conclusion, abnormal fucosylation might participate in the progress of esophageal squamous cell carcinoma and tissue-specific transplantation antigen P35B may serve as a novel biomarker for prognosis of patients with esophageal squamous cell carcinoma.

show abstract

Section: Discussionmentioning

confidence: 99%

High TSTA3 Expression as a Candidate Biomarker for Poor Prognosis of Patients With ESCC

Yang

Kong

Yang

et al. 2018

Technol Cancer Res Treat

View full text Add to dashboard Cite

show abstract

Screening of enzymatic synthesis and expression of Lewis determinants in human colorectal carcinoma

Abstract: Results suggest the activation of the biosynthesis pathways of mono- and difucosylated Lewis histo-blood antigens in tumour tissue from CRC patients, leading to the overexpression of Le(y), probably at the expense of Le(x).

Cited by 1 publication

References 38 publications

High TSTA3 Expression as a Candidate Biomarker for Poor Prognosis of Patients With ESCC

High TSTA3 Expression as a Candidate Biomarker for Poor Prognosis of Patients With ESCC

Contact Info

Product

Resources

About